Boehringer dual-acting obesity shot hits mark in Phase 3 trial
Survodutide spurred weight loss Wall Street analysts referred to as “Wegovy-like,” and showed signs it might help preserve muscle mass as well.
ORIGINAL SOURCE →via Biopharma Dive
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · US
- [CONFLICT] ABD basınından flaş iddia: İran’dan Hürmüz ve ateşkes için yeni teklif
- [CONFLICT] Brent petrol 105 doları aştı! Hürmüz krizi ve ABD-İran belirsizliği enerji piyasalarını sarsıyor
- [CONFLICT] ABD’de komplo teorileri neden arttı?
- [DIPLOMACY] Un chef con tres estrellas Michelin batió su récord de maratón Boston a los 48 años
- [FINANCE] American Tower Corporation Q1 2026 Earnings Call Summary
- [ENERGY] Gas prices hit record high; King Charles’s jaunt around DC